Multicentre Covariate Adjustment Analysis of Short-Term and 5-Year Outcomes after Endovascular Repair according to Sex
Table 3
Perioperative data, 30-day, and long-term outcomes.
Females (n = 57)
Males (n = 352)
value
Type of anaesthesia
0.725
Local/regional
16 (28.1%)
91 (25.9%)
General
41 (71.9%)
261 (74.1%)
Length of stay (days)
6 (4,9)
4 (3,7)
0.279
Length of ICU stay (days)
1 (1,2)
1 (1,2)
0.896
Intraoperative
Successful deployment
56 (98.2%)
346 (98.6%)
0.597
Death
—
—
Rupture
—
5 (1.4%)
1.000
Conversion to open
1 (1.8%)
4 (1.1%)
0.530
Endoleak
Type I
—
3 (0.85%)
1.000
Type II
4 (7.0%)
38 (10.8%)
0.362
Type III
—
2 (0.6%)
1.000
Type IV
—
1 (0.3%)
1.000
From operation to discharge
Wound infection
3 (5.3%)
8 (2.3%)
0.187
Seroma
1 (1.7%)
7 (2.0%)
1.000
Haematoma
5 (8.8%)
17 (4.8%)
0.253
Access vessel dissection
—
4 (1.1%)
1.000
False aneurysm
—
3 (0.8%)
1.000
Distal vessel embolization
—
2 (0.6%)
1.000
Ischaemic limb
1 (1.7%)
4 (1.1%)
0.530
Ischaemic colitis
—
1 (0.3%)
1.000
CVS
6 (10.5%)
27 (7.7%)
0.478
Pulmonary
1 (1.7%)
12 (3.4%)
1.000
Renal
3 (5.3%)
19 (5.4%)
0.967
GI bleed
—
2 (0.6%)
1.000
CNS
—
3 (0.8%)
1.000
30-day mortality
All cause
2 (3.5%)
1 (0.3%)
0.052
30-day composite outcome
Complications and mortality
18 (31.6%)
98 (27.8%)
0.562
Long-term outcomes at 5 years
All-cause mortality
15 (26.8%)
95 (27.5%)
0.907
Freedom from reintervention
35 (87.5%)
222 (88.8%)
0.812
MAE rate
20 (35.7%)
123 (35.5%)
0.981
Residual aneurysm size (mm)†
51.2 ± 17.2
53.2 ± 16.4
1.000
Note. ICU: intensive care unit; CVS: cardiovascular system; CNS: central nervous system; MAE: major adverse events. †5 women and 51 men had residual aneurysm.
